Phase III study comparing vinorelbine/gemcitabine with vinorelbine/carboplatin as first-line chemotherapy of advanced NSCLC: A Norwegian Lung Cancer Study Group trial.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7597 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7597-7597 ◽

Author(s):

Ø. Fløtten ◽

R. M. Bremnes ◽

B. H. Grønberg ◽

S. Sundstrøm ◽

T. Amundsen ◽

...

Keyword(s):

Lung Cancer ◽

Advanced Nsclc ◽

Phase Iii ◽

Study Group ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Phase Iii Study ◽

Group Trial ◽

Line Chemotherapy

Download Full-text

A Randomized Phase III Study of a Cisplatin (CDDP) and Docetaxel (DOC) with or without Irinotecan (CPT) in Patients with Advanced NSCLC: Okayama Lung Cancer Study Group OLCSG 0403 Trial

Annals of Oncology ◽

10.1016/s0923-7534(20)32011-1 ◽

2012 ◽

Vol 23 ◽

pp. xi34

Author(s):

E. Ichihara ◽

A. Hisamoto ◽

S. Harita ◽

Y. Segawa ◽

H. Kamei ◽

...

Keyword(s):

Lung Cancer ◽

Advanced Nsclc ◽

Phase Iii ◽

Study Group ◽

Cancer Study ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Phase Iii Study

Download Full-text

Phase II Study of the EGFR-TKI Rechallenge With Afatinib in Patients With Advanced NSCLC Harboring Sensitive EGFR Mutation Without T790M: Okayama Lung Cancer Study Group Trial OLCSG 1403

Clinical Lung Cancer ◽

10.1016/j.cllc.2016.07.003 ◽

2017 ◽

Vol 18 (2) ◽

pp. 241-244 ◽

Author(s):

Naohiro Oda ◽

Eiki Ichihara ◽

Katsuyuki Hotta ◽

Kiichiro Ninomiya ◽

Takashi Ninomiya ◽

...

Keyword(s):

Lung Cancer ◽

Phase Ii ◽

Egfr Mutation ◽

Advanced Nsclc ◽

Phase Ii Study ◽

Study Group ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Egfr Tki ◽

Download Full-text

Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Group

British Journal of Cancer ◽

10.1038/bjc.2012.284 ◽

2012 ◽

Vol 107 (3) ◽

pp. 442-447 ◽

Author(s):

Ø Fløtten ◽

B H Grønberg ◽

R Bremnes ◽

T Amundsen ◽

S Sundstrøm ◽

...

Keyword(s):

Advanced Nsclc ◽

Controlled Trial ◽

Phase Iii ◽

Study Group ◽

Line Treatment ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Randomised Controlled ◽

First Line Treatment

Download Full-text

A randomized phase III study of cisplatin and docetaxel with or without irinotecan in pts with advanced non-small cell lung cancer: Okayama Lung Cancer Study Group OLCSG 0403.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7584 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7584-7584

Author(s):

K. Kiura ◽

M. Tabata ◽

N. Takigawa ◽

S. Kuyama ◽

Y. Segawa ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Study Group ◽

Small Cell Lung ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Phase Iii Study

Download Full-text

Patients’ preferences and perceptions of lung cancer treatment decision making: results from Okayama lung cancer study group trial 1406

Acta Oncologica ◽

10.1080/0284186x.2019.1679880 ◽

2019 ◽

Vol 59 (3) ◽

pp. 324-328

Author(s):

Go Makimoto ◽

Katsuyuki Hotta ◽

Isao Oze ◽

Kiichiro Ninomiya ◽

Masamoto Nakanishi ◽

...

Keyword(s):

Lung Cancer ◽

Decision Making ◽

Cancer Treatment ◽

Treatment Decision ◽

Study Group ◽

Cancer Study ◽

Treatment Decision Making ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Download Full-text

A phase II trial of EGFR-TKI readministration with afatinib in advanced non-small-cell lung cancer harboring a sensitive non-T790M EGFR mutation: Okayama Lung Cancer Study Group trial 1403

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-018-3694-5 ◽

2018 ◽

Vol 82 (6) ◽

pp. 1031-1038 ◽

Author(s):

Naohiro Oda ◽

Kastuyuki Hotta ◽

Kiichiro Ninomiya ◽

Daisuke Minami ◽

Eiki Ichihara ◽

...

Keyword(s):

Lung Cancer ◽

Egfr Mutation ◽

Phase Ii Trial ◽

Study Group ◽

Small Cell Lung ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Egfr Tki ◽

Download Full-text

Phase II study of S-1 in patients with previously-treated invasive thymoma and thymic carcinoma: North Japan lung cancer study group trial 1203

Lung Cancer ◽

10.1016/j.lungcan.2019.10.016 ◽

2020 ◽

Vol 139 ◽

pp. 89-93 ◽

Author(s):

Yoko Tsukita ◽

Akira Inoue ◽

Shunichi Sugawara ◽

Shoichi Kuyama ◽

Taku Nakagawa ◽

...

Keyword(s):

Lung Cancer ◽

Phase Ii ◽

Thymic Carcinoma ◽

Phase Ii Study ◽

Study Group ◽

Invasive Thymoma ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Previously Treated ◽

Download Full-text

Short-term low-volume hydration in cisplatin-based chemotherapy for patients with lung cancer: the second prospective feasibility study in the Okayama Lung Cancer Study Group Trial 1201

International Journal of Clinical Oncology ◽

10.1007/s10147-015-0860-1 ◽

2015 ◽

Vol 21 (1) ◽

pp. 81-87 ◽

Author(s):

Kiichiro Ninomiya ◽

Katsuyuki Hotta ◽

Akiko Hisamoto-Sato ◽

Eiki Ichihara ◽

Hiroko Gotoda ◽

...

Keyword(s):

Lung Cancer ◽

Feasibility Study ◽

Study Group ◽

Cancer Study ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Download Full-text

Conventional radiation (RT) with daily carboplatin (Cb) compared to RT alone after induction chemotherapy (ICT) [vinorelbine (Vr)-cisplatine (P)]: Final results of a randomized phase III trial in stage III unresectable non small cell lung (NSCLC) cancer. Study CRG/BMS/NPC/96 of the French Lung Cancer Study Group FNCLCC and IFCT

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.7016 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7016-7016 ◽

Author(s):

R. Gervais ◽

A. Ducolone ◽

T. Lechevalier ◽

A. Legroumellec ◽

E. Lemarie ◽

...

Keyword(s):

Lung Cancer ◽

Phase Iii ◽

Study Group ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Cancer Study ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Conventional Radiation

Download Full-text

Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group

European Journal of Cancer ◽

10.1016/j.ejca.2011.03.035 ◽

2011 ◽

Vol 47 (10) ◽

pp. 1546-1555 ◽

Author(s):

Andrea Koch ◽

Bengt Bergman ◽

Erik Holmberg ◽

Christer Sederholm ◽

Lars Ek ◽

...

Keyword(s):

Lung Cancer ◽

Phase Iii ◽

Study Group ◽

Small Cell Lung ◽

Double Blind ◽

Phase Iii Trial ◽

Clinical Phase ◽

Cancer Study Group ◽

Lung Cancer Study Group

Download Full-text